Log in

NASDAQ:CODXCo-Diagnostics Earnings Date, Estimates & History

$18.00
+0.53 (+3.03 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$17.05
Now: $18.00
$18.00
50-Day Range
$8.70
MA: $14.74
$23.42
52-Week Range
$0.69
Now: $18.00
$29.72
Volume1.97 million shs
Average Volume9.32 million shs
Market Capitalization$494.28 million
P/E RatioN/A
Dividend YieldN/A
Beta-2.49

Earnings

Co-Diagnostics (NASDAQ:CODX) Earnings Information

Co-Diagnostics last released its earnings data on May 14th, 2020. The reported ($0.05) EPS for the quarter, missing analysts' consensus estimates of ($0.04) by $0.01. The company earned $1.55 million during the quarter, compared to analysts' expectations of $1.10 million. Co-Diagnostics has generated ($0.36) earnings per share over the last year. Co-Diagnostics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 12th, 2020 based off prior year's report dates.

Co-Diagnostics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Co-Diagnostics (NASDAQ:CODX) Earnings Estimates

Current Year EPS Consensus Estimate: $1.92 EPS
Next Year EPS Consensus Estimate: $1.25 EPS

Co-Diagnostics (NASDAQ CODX) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/12/2020
(Estimated)
       
5/14/20203/31/2020($0.04)($0.05)($0.05)$1.10 million$1.55 millionN/A
3/31/2020Q4($0.09)($0.09)($0.10)$0.15 million$0.11 millionN/A
11/13/2019Q3 2019($0.08)($0.10)($0.10)$0.10 million$0.04 millionN/A
8/14/2019Q2($0.0550)($0.08)($0.08)$0.06 millionN/A
5/15/20193/31/2019($0.08)($0.09)($0.09)$0.50 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 6/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.